491 related articles for article (PubMed ID: 16962751)
21. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
22. 5β-Cholanic Acid/Glycol Chitosan Self-Assembled Nanoparticles (5β-CHA/GC-NPs) for Enhancing the Absorption of FDs and Insulin by Rat Intestinal Membranes.
Yan C; Gu J; Lv Y; Shi W; Huang Z; Liao Y
AAPS PharmSciTech; 2019 Jan; 20(1):30. PubMed ID: 30603934
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
[TBL] [Abstract][Full Text] [Related]
24. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
[TBL] [Abstract][Full Text] [Related]
25. Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Bonferoni MC; Sandri G; Rossi S; Ferrari F; Gibin S; Caramella C
Eur J Pharm Sci; 2008 Feb; 33(2):166-76. PubMed ID: 18248966
[TBL] [Abstract][Full Text] [Related]
26. Combining Chemical Permeation Enhancers for Synergistic Effects.
du Toit T; Malan MM; Lemmer HJ; Gouws C; Aucamp ME; Breytenbach WJ; Hamman JH
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):575-86. PubMed ID: 25939330
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
Chen F; Zhang ZR; Yuan F; Qin X; Wang M; Huang Y
Int J Pharm; 2008 Feb; 349(1-2):226-33. PubMed ID: 17825506
[TBL] [Abstract][Full Text] [Related]
28. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Thanou M; Verhoef JC; Marbach P; Junginger HE
J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
[TBL] [Abstract][Full Text] [Related]
29. In vitro and ex vivo intestinal tissue models to measure mucoadhesion of poly (methacrylate) and N-trimethylated chitosan polymers.
Keely S; Rullay A; Wilson C; Carmichael A; Carrington S; Corfield A; Haddleton DM; Brayden DJ
Pharm Res; 2005 Jan; 22(1):38-49. PubMed ID: 15771228
[TBL] [Abstract][Full Text] [Related]
30. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
31. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
32. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
33. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
[TBL] [Abstract][Full Text] [Related]
34. Hydrocaffeic acid-chitosan nanoparticles with enhanced stability, mucoadhesion and permeation properties.
Soliman GM; Zhang YL; Merle G; Cerruti M; Barralet J
Eur J Pharm Biopharm; 2014 Nov; 88(3):1026-37. PubMed ID: 25281213
[TBL] [Abstract][Full Text] [Related]
35. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties.
Rahmat D; Müller C; Shahnaz G; Leithner K; Laffleur F; Khan MI; Martien R; Bernkop Schnürch A
Drug Dev Ind Pharm; 2013 Sep; 39(9):1338-45. PubMed ID: 22901004
[TBL] [Abstract][Full Text] [Related]
36. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
37. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
38. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells.
Hamman JH; Schultz CM; Kotzé AF
Drug Dev Ind Pharm; 2003 Feb; 29(2):161-72. PubMed ID: 12648013
[TBL] [Abstract][Full Text] [Related]
39. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
40. Chitosan ascorbate: a chitosan salt with improved penetration enhancement properties.
Rossi S; Marciello M; Sandri G; Bonferoni MC; Ferrari F; Caramella C
Pharm Dev Technol; 2008; 13(6):513-21. PubMed ID: 18720244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]